Phapros Tbk.

PEHA · Kesehatan · Farmasi & Riset Kesehatan

248

-24.39% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 48

  • Value

    87Against 788 other IDX companies

    Cheap against comparable stocks on earnings, book value and dividends.

    P/E
    5.1×
    91%Cheaper than 91% of other IDX companies
    P/B
    0.49×
    82%Cheaper than 82% of other IDX companies
    Dividend yield
    —
    —Not ranked
  • Quality

    55Against 788 other IDX companies

    About as profitable as comparable stocks.

    Return on equity
    9.6%
    67%Higher than 67% of other IDX companies
    Return on assets
    2.8%
    49%Higher than 49% of other IDX companies
    Net margin
    4.1%
    49%Higher than 49% of other IDX companies
  • Growth

    49Against 788 other IDX companies

    Growing roughly in line with comparable stocks.

    Profit, last 4 quarters
    —
    —Not ranked
    Profit, 3-year yearly
    0%
    42%Higher than 42% of other IDX companies
    Profit, latest quarter vs a year ago
    +69.2%
    73%Higher than 73% of other IDX companies
    Revenue, latest quarter vs a year ago
    +1.6%
    33%Higher than 33% of other IDX companies
  • Momentum

    45Against 836 traded stocks

    Near the middle of the market over the past year.

    1-year price change
    -23%
    45%Better than 45% of traded stocks
  • Liquidity

    17Against 836 traded stocks

    Thinly traded compared with most IDX stocks.

    Value traded per day, 30 days
    IDR 99M
    17%Higher than 17% of traded stocks
  • Retail penalty

    −3Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 50% of the other stocks where it is, so 3 points come off the rating.

    Retail average buy
    295
    Close vs that average
    -16%
    Retail net bought
    +3.6K lots

Similar stocks

Rated most like PEHA across the five pillars. Change is over the past year.